(Q30567158)

English

Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

1 reference

based on heuristic

inferred from title

Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Umberto D'Alessandro

3

object named as

Umberto D'Alessandro

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Paula Williamson

2

object named as

Paula Williamson

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Catrin Tudur Smith

5

object named as

Catrin Tudur Smith

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

author name string

Sarah Donegan

1

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

language of work or name

0 references

publication date

17 September 2012

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Statistics in Medicine

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

914-930

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Meta-analyses using individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Meta-analysis of individual participant data: rationale, conduct, and reporting

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Covariate heterogeneity in meta-analysis: criteria for deciding between meta-regression and individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

An overview of methods and empirical comparison of aggregate data and individual patient data results for investigating heterogeneity in meta-analysis of time-to-event outcomes

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Meta-analysis of continuous outcomes combining individual patient data and aggregate data

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Meta-analysis of individual- and aggregate-level data.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Combination of direct and indirect evidence in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Evaluation of networks of randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Borrowing strength from external trials in a meta-analysis.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Indirect comparisons of competing interventions

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Exploring the geometry of treatment networks.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: Application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Multiple treatment comparisons in epilepsy monotherapy trials

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Meta-analysis of a binary outcome using individual participant data and aggregate data

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Network meta-analysis with competing risk outcomes

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Network meta-analysis of survival data with fractional polynomials

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artemisinin-based combination therapy for treating uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Comparative efficacy of antimalarial drugs including ACTs in the treatment of uncomplicated malaria among children under 5 years in Ghana

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A randomised trial to assess the safety and efficacy of artemether-lumefantrine (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwanda

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Bayesian measures of model complexity and fit

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Modeling between-trial variance structure in mixed treatment comparisons

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FSIM.5584

21 January 2018

Identifiers

10.1002/SIM.5584

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30567158&oldid=1645020235"